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Abstract
Background: In eukaryotes mRNA transcripts of protein-coding genes in which an intron has been retained in the coding
region normally result in premature stop codons and are therefore degraded through the nonsense-mediated mRNA decay
(NMD) pathway. There is evidence in the form of selective pressure for in-frame stop codons in introns and a depletion of
length three introns that this is an important and conserved quality-control mechanism. Yet recent reports have revealed
that the efficiency of NMD varies across tissues and between individuals, with important clinical consequences.
Principal Findings: Using previously published Affymetrix exon microarray data from cell lines genotyped as part of the
International HapMap project, we investigated whether there are heritable, inter-individual differences in the abundance of
intron-containing transcripts, potentially reflecting differences in the efficiency of NMD. We identified intronic probesets
using EST data and report evidence of heritability in the extent of intron expression in 56 HapMap trios. We also used a
genome-wide association approach to identify genetic markers associated with intron expression. Among the top
candidates was a SNP in the DCP1A gene, which forms part of the decapping complex, involved in NMD.
Conclusions: While we caution that some of the apparent inter-individual difference in intron expression may be
attributable to different handling or treatments of cell lines, we hypothesize that there is significant polymorphism in the
process of NMD, resulting in heritable differences in the abundance of intronic mRNA. Part of this phenotype is likely to be
due to a polymorphism in a decapping enzyme on human chromosome 3.
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Introduction
The transcriptome of higher eukaryotes is complex and diverse,
with multiple isoforms present for most genes, resulting from
heterogeneity at several stages of the generation and processing of
RNA from transcription initiation to splicing and polyadenylation.
The diversity of the splicing step has been intensively studied.
Microarrays that target splice junctions were used to demonstrate
that the majority of human genes are alternatively spliced [1] and,
more recently, next generation sequencing has provided even
greater resolution [2,3] such that alternatively spliced isoforms
have now been observed from almost all human multi-exon genes.
In addition to diversity across tissues, transcript isoforms show
diversity between individuals, with about 20% of alternatively
spliced genes showing evidence of inter-individual differences in
relative isoform abundance [2,4]. Mutations that affect splicing
appear to be responsible for a large proportion of human genetic
diseases (see [5,6] for reviews) and may even be the largest
contributor to human genetic diseases resulting from single point
mutations [7]. Researchers investigating the potential functional
implications of genetic variants have often tended to ignore
splicing effects [5], although, recently, there have been several
large-scale studies to identify common genetic variants with an
effect on mRNA splicing [4,8,9,10,11,12,13,14,15]. These studies
parallel efforts to determine the genetic contribution to gene
expression variation (for review see [16]).
The rate at which mRNA of a transcript comes into the system
is just one part of the equation determining mRNA levels.
Different mRNA isoforms have different stabilities and can have
decay rates ranging over orders of magnitude [17,18]. This
difference can be important for the regulation of gene expression
levels. For example, steady state expression levels of genes with
faster decay rates are altered more rapidly by changes in the rate
of transcription than genes with slower decay rates [18]. While for
most housekeeping genes decay rates are relatively constant, in
some cases decay rates are regulated by proteins that bind to
mRNA, with functional implications, for example in regulation of
immunity [19]. Decay of mRNA requires removal of the 59 7-
methylguanosine cap structure which is achieved by a decapping
complex [20]. This occurs following deadenylation in dead-
enylation-dependent mRNA decay but is also required in
nonsense-mediated decay (NMD) [20]. The NMD pathway
degrades mRNAs with premature stop codons and acts as a
surveillance step for incorrectly spliced or mutated transcripts.
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When coupled to regulated alternative splicing, it can be used as a
means of post-transcriptional regulation [21]. More generally,
NMD appears to be a key quality control step, conserved across
eukaryotes, that prevents translation of incompletely spliced
transcripts [22].
There is good evidence of variability in the efficiency of NMD
across tissues [23,24] and between individuals [25,26]. This
difference can have phenotypic and clinical implications [27], for
example in the severity of genetic diseases resulting from
premature termination codon (PTC) mutations [28] and in
individual-specific responses to drugs [29]. Tissue-specific differ-
ences in NMD can result in PTC mutations with a phenotype in
one tissue and not another. For example, a heterozygous PTC in
the gene for collagen X causes Schmid metaphyseal chondrodys-
plasia [24]. The phenotype is restricted to cartilage, where NMD
removes the PTC-containing transcripts, and the gene is not
subject to NMD in other cell types. A difference in the efficiency of
NMD has previously been reported to represent a stable
phenotype in human cell lines that can result from differences in
the abundance of NMD co-factors, possibly among other causes
[26]. In general, because degrading improperly spliced mRNA
from which introns have not been removed appears to be an
important role of NMD in eukaryotes [22] it is reasonable to
consider that there may be stable and heritable differences in the
proportion of undegraded intron-containing transcripts.
In this study, we set out to determine whether there is evidence
of transcriptome-wide differences in the abundance of intron-
containing mRNA isoforms observed in different cell lines, using
exon microarray data from published studies. We identified
putative intronic probesets on the Affymetrix Human Exon 1.0 ST
microarray and estimated the relative frequency with which these
probesets were included in the final transcript. Intron-containing
transcripts may be unprocessed, partially processed or fully
processed mRNA in which one or more introns have been
retained. Differences in the abundance of intron-containing
transcripts may, therefore, reflect differences in the efficiency of
splicing or in the efficiency with which intron-containing
transcripts are degraded through NMD.
The microarray data included 56 complete trios from the
HapMap [30] cell line panels originating from the Yoruba in
Ibadan, Nigeria (YRI) and from Utah residents with ancestry from
northern and western Europe (CEU). We calculated the
normalized expression intensity of intronic probesets and report
that the extent of intron expression shows evidence of heritability
in the cell lines from the HapMap trios. We then performed a
genome-wide association test, using parents of the HapMap trios
to identify loci that were associated with normalized expression
intensity of intronic probesets. One of the most significant peaks in
the results of this test was within DCP1A on chromosome 3. DCP1A
encodes a component of the decapping complex which is involved
in NMD [31,32]. A polymorphism at this locus was significantly
associated with higher relative expression intensity of intronic
probesets.
Results and Discussion
We used data generated with the Affymetrix Human Exon 1.0
ST array from human cell lines to investigate heritability in the
relative expression of introns in human. Because the probes on the
array target computationally predicted exons as well as known
exons and exons derived from ESTs and other sources, the
targeted regions are likely to include a proportion of introns as well
as correctly predicted exons. From among the approximately 1.4
million probesets on the array, we identified 269,007 that are likely
to lie within introns, as described in Methods. Raw intensity
(.CEL) data generated using this array by Huang et al. [33] was
downloaded from GEO and processed as described in the
Methods section. For each of these putative intronic probesets
we estimated the normalized intensity as the expression intensity of
the probeset divided by the metaprobeset-level summary value (i.e.
transcript-level expression intensity). Interestingly, the normalized
intensity of these intronic probesets was weakly, though highly
significantly negatively correlated (Spearman r=20.14;
p,1610216) with the half-life of the transcript to which they
mapped (mRNA half-lives estimated in human B cells were
obtained from a recent study [34]). This is consistent with
expectations because intron-containing transcripts are frequently
subject to degradation (e.g. through NMD) and for long-lived
transcripts, the fraction of the transcript pool corresponding to
intron-containing but as yet undegraded transcripts should be
lower than for transcripts with a higher turn over rate.
To investigate the possibility of transcriptome-wide differences
in the proportion of intron containing transcripts, we restricted to
those intronic probesets that were detectable above background
(p,0.05) in at least 20 of the 176 HapMap individuals and for
which at least one core probeset in the corresponding gene was
detectable above background in the majority of the individuals.
We then ranked the normalized intensities for the probeset across
all of the arrays and obtained a summary statistic for each array by
calculating the average rank of its normalized intensity values
across all intronic probesets. This intron expression summary
statistic showed substantial variability across arrays – indicating
that in some of the cell lines the normalized intensity of intronic
probesets (i.e. their relative inclusion in the mature transcript) is
generally lower than for other cell lines. Values ranged from 56.6
(indicating an array for which, on average, the normalized
intensity of intronic probesets ranked 56.6th out of 176 arrays, i.e.
in the lower 32.2%) to 119.4 (corresponding to the top 67.8%) for
the array with the highest value. The distribution of the summary
statistic across arrays is provided as supplementary figure S1.
Although there was evidence of substantial difference in relative
intron expression across arrays, it was not clear to what extent this
reflected biologically significant differences between the samples or
merely differences in the arrays or sample preparations. To
investigate this we obtained a second set of data, consisting of exon
microarrays applied to members of the CEPH 1444 pedigree by
Kwan et al. [11]. In this case exon microarray data were available
for three separate passages for four individuals as well as single
passages for a further 10 individuals. The data were analyzed as
described above. Five technical replicates for each of the three
biological replicates (separate cell passages) were available for two
of the cell lines (NA12750 and NA12751). Values of the intron
expression statistic calculated from these arrays suggest that
technical variation as well as variation between cell passages make
a contribution to the observed differences between arrays (Fig. 1a);
nonetheless, the difference between cell lines was highly statisti-
cally significant, despite the variation between repeats
(p = 1.061025, from a two-tailed t-test). Other than three of the
technical replicates of the first passage of NA12751, the two cell
lines were easily distinguishable. When we considered the data
from all cell lines for which biological replicates were available we
again found a significant difference across cell lines (Fig. 1b;
p = 5.761026 from a one-way ANOVA).
To search for evidence of heritability in relative intron
expression we returned to the exon array data from the HapMap
trios [30] and regressed the summary statistic obtained from the
offspring against the mean value of the parents (Fig. 2). This
suggests strong heritability of the relative intron expression
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(slope = 0.6060.28; p = 7.561025). There was evidence of herita-
bility, considering the CEU and YRI samples separately (p = 0.01
and p= 0.003 from the regressions of CEU and YRI trios,
respectively), providing an indication of the robustness of the result
to sampling and batch effects, especially as these samples were
collected decades apart [35]. Batch effects have been shown to be
a significant concern in microarray experiments [36] and this
study could be prone to such effects, given the observed variability
across biological and technical repeats (Fig. 1). Although, the
authors of the study from which the microarray data were
obtained took care to avoid batch effects [33], we also extracted
date information from the headers of the CEL files and found that
there was some evidence, albeit very weak, of members of the
same trio having similar processing dates (p = 0.05 from one-way
ANOVA of sampling times against trio membership). However,
this seems unlikely to be responsible for the strong heritability
evident in figure 2.
As an additional check, we also compared the intron expression
statistic between parents of the trios and found that these were
significantly correlated (r = 0.44; p = 0.0007), suggesting that a
batch effect may be involved in the apparent heritability of the
intron expression summary statistic. When we analyzed the CEU
and YRI samples separately we found that the correlation between
parents was significant only for the YRI (p = 0.0003 and p= 0.23
for the YRI and CEU trios, respectively). The YRI parents have
been found to be more closely related to one another than random
pairs of YRI samples while this was not the case for the parents of
the CEU trios [37]. But this is a relatively small effect (the parents
are not close relatives) and it therefore appears likely that there is a
non-genetic contribution to the similarity observed between the
YRI parents. However, there is no evidence of such an effect in the
CEU samples and the CEU and YRI trios provide similar
estimates of the heritability of the intron expression statistic (the
slope of the regression line is 0.69 with a standard error of 0.25 for
the CEU trios and 0.53 with a standard error of 0.16 for the YRI).
We used a genome-wide association approach to search for loci
that are associated with the relative intron expression statistic. To
avoid the inclusion of close relatives, we took only the data from
the parents of the HapMap trios and carried out an additive test of
association between SNPs genotyped as part of the HapMap
project and the intron expression summary statistic. We carried
out the test separately on the CEU and YRI samples, to avoid the
effects of this population structure on the analysis. Histograms of
the distributions of p-values obtained from individual tests of
association and qqplots of the logarithm to the base ten of the p
values against the logarithm of random draws from the uniform
distribution are shown in figure 3 for both populations. In these
plots it is clear that there were more low p values than expected
Figure 1. Reproducibility of the summary statistic of intron expression across replicate samples from a previous study. a) stripchart
showing technical and biological replicates for two lymphoblast cell lines. Separate cell passages are shown in different colours. b) boxplots and
superimposed stripcharts of biological replicates (separate cell passages) of four cell lines.
doi:10.1371/journal.pone.0011657.g001
Figure 2. Heritability of the mean expression intensity of
intronic probes. Points in the scatter plot of offspring values of the
summary statistic against mean of the parent values are colored in blue
for CEU trios and black for YRI trios. The estimated regression line (from
the combined data) together with upper (green) and lower (red)
bounds on the regression line estimates are shown.
doi:10.1371/journal.pone.0011657.g002
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under the uniform distribution, particularly in the YRI case,
pointing to a proportion of true positive associations between the
phenotype and a subset of the genetic markers. We used the
qvalue package [38,39] to estimate false discovery rates, bearing in
mind the caveat that linkage between SNPs results in non-
independent hypothesis tests. There were 45 markers with q values
less 0.05. These 45 markers occurred in 19 peaks of the genomic
plot of p values (Fig. 4).
Markers associated with the intron expression phenotype are
shown in Table 1. Of the 11 association peaks, four mapped within
or close to genes. The most significant peak was within the NRG3
gene on chromosome 10, which was associated with intron
expression in the CEU population. Although there is no obvious
association between NRG3 and RNA processing it is interesting
that a strong association to the same region of chromosome 10 was
also observed in the YRI population (Table 1). The most
promising of the associations was to a region of chromosome 3,
within the DCP1A gene which encodes the human homologue of
the yeast decapping enzyme, which, together with another
decapping enzyme forms the human decapping complex, a key
participant in deadenylation-dependent as well as nonsense-
mediated mRNA decay. In yeast, the rate of decapping is thought
to be a key determinant of the rate of mRNA decay and this gene
was first identified through the effect of mutants on NMD [40].
NMD also involves decapping in higher eukaryotes [41]. The
derived A allele of the G/A SNP which was associated with intron
content occurs at a frequency of 11% in YRI but is not found in
the non-African samples in HapMap II. Among the parents of the
YRI trios, thirteen were heterozygous but there were no
homozygous A individuals. The heterozygotes showed a greater
normalized expression intensity of intronic probesets than the
remainder of the parent samples (Fig. 5; p = 9.661028).
As a further test for evidence of a contribution of NMD to the
differences in the intron expression, observed between individuals,
we identified a set of unprocessed pseudogenes, expressed above
background (p,0.05) in at least 10 cell lines. Because NMD is
involved in degrading pseudogenes [42] we hypothesized that the
expression level of pseudogenes might be correlated with the
intron expression statistic and show differences between individ-
uals with different genotypes at the DCP1A locus. For each
metaprobeset corresponding to one of the unprocessed pseudo-
genes we calculated the Spearman correlation coefficient between
the metagene expression level and the intron expression statistic
and compared these numbers to correlation coefficients obtained
for non-pseudogenes. The Spearman rho statistics obtained from
the processed pseudogenes were higher than for other genes
(p = 0.003; Wilcoxon rank-sum test). For three of the 16
pseudogenes the correlation between expression level and the
intron expression statistic was nominally significant (a=0.05).
Similarly, the expression levels of the pseudogenes were much
more likely to be affected by the genotype at the DCP1A locus than
other genes (p = 0.006, based on a t-test of t-statistics from 2-
sample t-tests). In the case of four pseudogenes the differences in
expression levels of were nominally significant (a=0.05), and, in
Figure 3. Histograms of p-values from tests of association between individual SNP markers and the intron expression phenotype in
the CEU (a) and YRI (b) populations. Quantile-quantile plots of log10 of the p-values from the CEU (c) and YRI (d) association tests against log10 of
random values, drawn from the uniform distribution.
doi:10.1371/journal.pone.0011657.g003
Heritability in NMD Efficiency
PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11657
each case the pseudogene was more highly expressed in
heterozygotes than homozygotes, as expected.
In conclusion, we found evidence that the normalized
expression intensity, averaged across intronic probesets, shows
reproducible differences between individuals and report that this
appears to be a heritable trait in humans. However, we caution
that this analysis is subject to any batch effects relating to the
collection and treatment of the cell lines and report a correlation
between parents of the YRI HapMap trios that we were not able
to explain fully. This is the first study to explore transcript-wide
differences between human individuals in the types of mRNA
isoforms observed and it points to the contribution of trans-
acting factors to the diversity of the transcriptome. To
investigate what some of these trans factors might be we carried
out a genome-wide association test of this phenotype using the
densely genotyped HapMap cell lines and found several
association peaks, including a strong association with one very
plausible candidate gene – DCP1A, a component of the mRNA
Table 1. Markers associated with the intron expression phenotype with q-values,0.05.
SNP Location Function Associated gene Population P-value
rs7088129 10: 84230104 Intronic NRG3 CEU 1.961029
rs659554 10: 84341085 Intronic NRG3 CEU 1.261028
rs2115904 15: 29424204 Intergenic None YRI 9.261029
rs4878127 9: 89577039 Near 59 CTSL3 YRI 7.161028
rs17053466 9: 89579157 Intronic CTSL3 YRI 7.161028
rs10512189 9: 89580577 Intronic CTSL3 YRI 7.161028
rs9311496 3: 53347118 Intronic DCP1A YRI 9.661028
rs16889633 6: 24811421 Intergenic None YRI 1.161027
rs686394 12: 9966342 Intergenic None YRI 1.361027
rs17101452 14: 74157738 Intergenic None YRI 2.061027
rs888419 14: 74158848 Intergenic None YRI 2.061027
rs4899337 14: 69740936 Intergenic None YRI 3.561027
rs13329672 15: 56487229 Intergenic None YRI 3.561027
rs410509 3: 5216309 Synonymous EDEM1 YRI 3.561027
rs377120 3: 5216223 Intronic EDEM1 YRI 3.661029
rs11201378 10: 86856283 Intergenic None YRI 3.761027
rs12244919 10: 86860618 Intergenic None YRI 3.761027
rs12252660 10: 86860718 Intergenic None YRI 3.761027
rs11201382 10: 86862554 Intergenic None YRI 3.761027
The table shows the combined results of the association test in the CEU and YRI populations.
doi:10.1371/journal.pone.0011657.t001
Figure 4. Genomic distribution of p-values from association tests. Successive chromosomes are shown in alternating colours on the plot.
Results from the CEU and YRI populations are shown in panels a and b, respectively.
doi:10.1371/journal.pone.0011657.g004
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decapping complex. We propose that the derived allele of this
SNP, which occurs at about 11% frequency in YRI and was not
found in the CEU samples, is linked to a less efficient form of




Raw microarray intensity data generated using the Affymetrix
GeneChip Human Exon 1.0 ST array from 176 HapMap cell
lines by Huang et al. [33] and from 14 cell lines from CEPH
pedigree 1444 by Kwan et al. [11] were obtained from GEO and
processed using the Affymetrix Power Tools as described
previously [8]. Publicly available genotype data for almost four
million markers were downloaded from the HapMap [30].
BLAT [43] alignments of EST sequences to the human genome
were downloaded from UCSC (hg18, corresponding to NCBI
genome build 36.1) on 17/3/2008. Only ESTs that mapped to
the genome exactly once, with at least 95% identity over at least
90% of the length of the EST sequence were considered. mRNA
half-life data in human B cells were obtained from a recent
study [34].
Identification of intronic probesets
For each probeset from the exon array, we counted the number
of times the probeset was within the spliced portion of an EST,
thus putatively in an intron. Spliced portions of ESTs were
inferred from gaps in the alignments of ESTs to the genome, of at
least 50 bp, surrounded by upstream and downstream aligned
blocks of at least 20 bp. We also counted the number of times the
probeset fell within the exonic (i.e. aligned) portion of an EST.
Probesets that occurred in intron-like gaps in the genomic
alignments of at least 10 ESTs and which occurred at least five
times as frequently in gaps than in aligned blocks were designated
as intronic. In some cases, these probesets may overlap skipped
exons that are included infrequently in the mature transcript.
However, given the large number of probesets identified in intron-
like alignment gaps (269,0007) and given the much greater length
of introns than exons, the majority of these probesets are likely to
be non-exonic.
Summary statistic of relative intron expression
We calculated normalized probeset intensity by dividing the
probeset intensity by the estimated intensity of the corresponding
meta-probeset (i.e. transcript) [44]. For each intronic probeset,
identified as described above, we compared the normalized
intensity to the normalized intensity of the same probeset in the
other cell lines in order to obtain a rank ordering of the
normalized intensities for the probeset across cell lines. This gives
an indication of how frequently the intronic probeset is retained in
the mature transcript, in a given cell line, compared to the other
cell lines. This quantity was averaged across all probesets to obtain
a summary statistic of the relative expression intensity of intronic
probesets. The heritability of this quantity was investigated by
regressing the child values against the mean of the parent values in
HapMap trios for which microarray data were available for the
offspring and both parents (56 trios).
Genome-wide association test
We obtained genotype data from the CEU and YRI trios from
HapMap [30]. To remove obvious close relatives we discarded the
child data and considered only the parents of the trios. To avoid
the effects of population structure between the YRI and CEU, we
performed the test of association separately for each population
group. To reduce the size of the multiple hypothesis testing
problem we removed markers with fewer than 5 heterozygotes.
We also considered only autosomal markers. We used the R
package GenABEL [45] to perform additive tests of association
(i.e. a linear model of the phenotype against the number of copies
of the non-reference allele – zero for reference allele homozygotes,
one for heterozygotes and two for non-reference allele homozy-
gotes). We used the qvalue package within R for multiple test
correction and investigated peaks in the p value distribution with q
values below 0.25.
Supporting Information
Figure S1 Distribution of the summary statistic of intron
expression across cell lines.
Found at: doi:10.1371/journal.pone.0011657.s001 (1.32 MB TIF)
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